Why Is Milestone Pharmaceuticals Stock Plunging On Friday?

benzinga.com/news/fda/25/07/46372110/why-is-milestone-pharmaceuticals-stock-plunging-on-friday

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) moved closer to potential FDA approval for its Cardamyst (etripamil) nasal spray, an investigational therapy for paroxysmal supraventricular tachycardia (PSVT), as the U.S. Food and Drug Administration (FDA) accepted the company’s response to…

This story appeared on benzinga.com, 2025-07-11 16:22:43.
The Entire Business World on a Single Page. Free to Use →